THE NICKLES GROUP, LLC for NOVO NORDISK, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to compounding and counterfeit drugs. H.R. 2715, Destruction of Hazardous Imports Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
| JEFF CHOUDHRY | — |
| GREG D'ANGELO | — |
| MOLLY FROMM | — |
| MARY BETH SAVARY TAYLOR | — |
Medicare/Medicaid MMM
Issues related to drug pricing and implementation of the Inflation Reduction Act. H.R. 1492, the Ensuring Pathways to Innovative Cures Act. Issues related to coverage of anti-obesity medications. Issues related to pharmacy benefit management reforms. Issues related to Most Favored Nation drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
| JEFF CHOUDHRY | — |
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Taxation/Internal Revenue Code TAX
Monitored issues related to the implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes and foreign-based multinationals. Monitor OECD negotiations on the Pillar II global minimum tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MOLLY FROMM | — |
| RACHEL JONES HENSLER | — |
Trade (domestic/foreign) TRD
Issues related to tariffs. Issues related to importation of counterfeit drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MOLLY FROMM | — |
| LUCAS HOLLAND | — |
| RACHEL JONES HENSLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.